(Q34715264)

4 August 2017

title

Breaking the one antibody-one target axiom (English)

1 reference

4 August 2017

1 reference

4

Carlos F Barbas

1 reference

4 August 2017

Fang Guo

1

1 reference

4 August 2017

Sanjib Das

2

1 reference

4 August 2017

Barbara M Mueller

3

1 reference

4 August 2017

Richard A Lerner

5

1 reference

4 August 2017

Subhash C Sinha

6

1 reference

4 August 2017

language of work or name

English

0 references

publication date

5 July 2006

1 reference

Proceedings of the National Academy of Sciences of the United States of America

4 August 2017

published in

1 reference

4 August 2017

volume

103

1 reference

4 August 2017

issue

29

1 reference

4 August 2017

page(s)

11009-11014

1 reference

Integrins and angiogenesis

4 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1488731

Combinatorial antibody libraries from cancer patients yield ligand-mimetic Arg-Gly-Asp-containing immunoglobulins that inhibit breast cancer metastasis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1488731

Chemical adaptor immunotherapy: design, synthesis, and evaluation of novel integrin-targeting devices.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1488731

Engineering antibodies for clinical applications in cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1488731

Anti-metastatic properties of RGD-peptidomimetic agents S137 and S247.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1488731

A humanized aldolase antibody for selective chemotherapy and adaptor immunotherapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1488731

Chemically programmed monoclonal antibodies for cancer therapy: adaptor immunotherapy based on a covalent antibody catalyst.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1488731

In vivo activity in a catalytic antibody-prodrug system: Antibody catalyzed etoposide prodrug activation for selective chemotherapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1488731

Integrin activation controls metastasis in human breast cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1488731

Nonpeptide alpha(v)beta(3) antagonists. 1. Transformation of a potent, integrin-selective alpha(IIb)beta(3) antagonist into a potent alpha(v)beta(3) antagonist

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1488731

Multiple event activation of a generic prodrug trigger by antibody catalysis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1488731

Fluorescent probes for confocal microscopy.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1488731

Aldol sensors for the rapid generation of tunable fluorescence by antibody catalysis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1488731

Expression of alphav integrins and vitronectin receptor identity in breast cancer cells

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1488731

Immune versus natural selection: antibody aldolases with enzymic rates but broader scope

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1488731

Efficient aldolase catalytic antibodies that use the enamine mechanism of natural enzymes

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1488731

Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1488731

RGD peptides and monoclonal antibodies, antagonists of alpha(v)-integrin, enter the cells by independent endocytic pathways.

7 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1073%2FPNAS.0603822103

Small molecule drug activity in melanoma models may be dramatically enhanced with an antibody effector

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16822849

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Integrin alpha V beta 3 expression by bone-residing breast cancer metastases

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16822849

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Monoclonal antibody therapy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16822849

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1073/PNAS.0603822103

1 reference

4 August 2017

0 references

1 reference

4 August 2017

1 reference